Needle-free vaccine delivery platforms can solve the problems of stockpiling, cold-chain management, and pandemic preparedness.
Timothy Sullivan
Advertisement
Timothy Sullivan is the president and CEO at Mystic Pharmaceuticals, Inc.
Articles by Timothy Sullivan
Advertisement
Latest Updated Articles
Innovations in Intranasal Vaccine Delivery TechnologyPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
